Table 1

Characteristics of patients

Patient no.Age/genderAffected
eye
History of ocular diseaseDuration before CMV detection (months)History of antiviral medicationHistory of topical antiviral medication
176/MLeft57Valganciclovir oral0.15% Ganciclovir gel
238/MLeft12
328/MLeft18
459/MLeftCorneal decompensate57IV ganciclovir0.15% Ganciclovir gel
550/FRight204
653/MLeftPrimary open angle glaucoma62
752/MRight62
841/MLeftBehcet’s disease on cyclophosphamide1IVT ganciclovir
933/FLeft48
1081/MLeftS/P PKP60
1129/FRightS/P PKP14
  • M, male; F, female; IV, intravenous; IVT, intravitreous; S/P PKP, post penetrating keratopathy.